The UK Competition Authority finds that pharmaceutical companies took part in a market sharing arrangements (Lexon / Medreich)

In recent years, the UK CMA has focussed many of its investigations on the pharmaceutical sector. This is partly due to the fact that in the UK, the National Health Service is a public funded body which bears most of the cost of the majority of

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Bird & Bird (London)
  • Bird & Bird (London)

Citation

Ariane Le Strat, Peter Willis, The UK Competition Authority finds that pharmaceutical companies took part in a market sharing arrangements (Lexon / Medreich), 18 juin 2019, e-Competitions June 2019, Art. N° 94401

Visites 29

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues